Css LLC Iveric Bio, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $2.79 Million - $4.22 Million	106,500 New	106,500 $4.19 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $372,240 - $736,164	39,600 Added 81.48%	88,200 $1.58 Million
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $320,112 - $663,390	35,100 Added 260.0%	48,600 $468,000
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $164,025 - $227,204	13,500 New	13,500 $227,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.